黃正谷

This profile gathers the share dealings of 黃正谷 in 藥華藥. We count 4 filings; the first trade dates from 4 July 2016 and the latest from 23 June 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The latest filing, published on 23 June 2026, reports a transaction in 藥華藥. Publication is fast: at least half of the trades appear on TWSE / TPEx (MOPS) on the same day. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by TWSE / TPEx (MOPS). They describe what insiders did and are not a recommendation.